GENB: Generate Biomedicines, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
86 institutions reported holding $1.65B of Generate Biomedicines, Inc. on Form 13F (57 the quarter before). 42 opened a new position and 13 sold out. Shares held by institutions: +8%.
| Largest holders | Shares | Value |
|---|---|---|
| Flagship Pioneering, LLC | 62,673,117 | $1.06B |
| FMR LLC | 5,221,599 | $88.09M |
| Capital World Investors | 4,215,632 | $71.12M |
| BRAIDWELL LP | 3,283,844 | $55.40M |
| NORGES BANK | 2,094,616 | $35.34M |
| ARCH Venture Management, LLC | 1,944,426 | $32.80M |
| HarbourVest Partners LLC | 1,722,210 | $29.05M |
| BlackRock, Inc. | 1,659,966 | $28.00M |
| BAKER BROS. ADVISORS LP | 1,423,602 | $24.02M |
| JPMORGAN CHASE & CO | 1,409,649 | $23.84M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.